Global Necrotizing Fasciitis Market Research Report 2023

Report ID: 1988702 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Necrotizing Fasciitis Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Intravenous Antibiotics
        1.2.3 Surgery
        1.2.4 Hyperbaric Oxygen Treatment
    1.3 Market by Application
        1.3.1 Global Necrotizing Fasciitis Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital & Clinics
        1.3.3 Surgical Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Necrotizing Fasciitis Market Perspective (2017-2028)
    2.2 Necrotizing Fasciitis Growth Trends by Region
        2.2.1 Necrotizing Fasciitis Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Necrotizing Fasciitis Historic Market Size by Region (2017-2022)
        2.2.3 Necrotizing Fasciitis Forecasted Market Size by Region (2023-2028)
    2.3 Necrotizing Fasciitis Market Dynamics
        2.3.1 Necrotizing Fasciitis Industry Trends
        2.3.2 Necrotizing Fasciitis Market Drivers
        2.3.3 Necrotizing Fasciitis Market Challenges
        2.3.4 Necrotizing Fasciitis Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Necrotizing Fasciitis Players by Revenue
        3.1.1 Global Top Necrotizing Fasciitis Players by Revenue (2017-2022)
        3.1.2 Global Necrotizing Fasciitis Revenue Market Share by Players (2017-2022)
    3.2 Global Necrotizing Fasciitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Necrotizing Fasciitis Revenue
    3.4 Global Necrotizing Fasciitis Market Concentration Ratio
        3.4.1 Global Necrotizing Fasciitis Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Necrotizing Fasciitis Revenue in 2021
    3.5 Necrotizing Fasciitis Key Players Head office and Area Served
    3.6 Key Players Necrotizing Fasciitis Product Solution and Service
    3.7 Date of Enter into Necrotizing Fasciitis Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Necrotizing Fasciitis Breakdown Data by Type
    4.1 Global Necrotizing Fasciitis Historic Market Size by Type (2017-2022)
    4.2 Global Necrotizing Fasciitis Forecasted Market Size by Type (2023-2028)
5 Necrotizing Fasciitis Breakdown Data by Application
    5.1 Global Necrotizing Fasciitis Historic Market Size by Application (2017-2022)
    5.2 Global Necrotizing Fasciitis Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Necrotizing Fasciitis Market Size (2017-2028)
    6.2 North America Necrotizing Fasciitis Market Size by Country (2017-2022)
    6.3 North America Necrotizing Fasciitis Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Necrotizing Fasciitis Market Size (2017-2028)
    7.2 Europe Necrotizing Fasciitis Market Size by Country (2017-2022)
    7.3 Europe Necrotizing Fasciitis Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Necrotizing Fasciitis Market Size (2017-2028)
    8.2 Asia-Pacific Necrotizing Fasciitis Market Size by Country (2017-2022)
    8.3 Asia-Pacific Necrotizing Fasciitis Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Necrotizing Fasciitis Market Size (2017-2028)
    9.2 Latin America Necrotizing Fasciitis Market Size by Country (2017-2022)
    9.3 Latin America Necrotizing Fasciitis Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Necrotizing Fasciitis Market Size (2017-2028)
    10.2 Middle East & Africa Necrotizing Fasciitis Market Size by Country (2017-2022)
    10.3 Middle East & Africa Necrotizing Fasciitis Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Necrotizing Fasciitis Introduction
        11.1.4 Merck Revenue in Necrotizing Fasciitis Business (2017-2022)
        11.1.5 Merck Recent Development
    11.2 Wockhardt
        11.2.1 Wockhardt Company Detail
        11.2.2 Wockhardt Business Overview
        11.2.3 Wockhardt Necrotizing Fasciitis Introduction
        11.2.4 Wockhardt Revenue in Necrotizing Fasciitis Business (2017-2022)
        11.2.5 Wockhardt Recent Development
    11.3 Atox Bio
        11.3.1 Atox Bio Company Detail
        11.3.2 Atox Bio Business Overview
        11.3.3 Atox Bio Necrotizing Fasciitis Introduction
        11.3.4 Atox Bio Revenue in Necrotizing Fasciitis Business (2017-2022)
        11.3.5 Atox Bio Recent Development
    11.4 Teva Pharmaceutical Industries
        11.4.1 Teva Pharmaceutical Industries Company Detail
        11.4.2 Teva Pharmaceutical Industries Business Overview
        11.4.3 Teva Pharmaceutical Industries Necrotizing Fasciitis Introduction
        11.4.4 Teva Pharmaceutical Industries Revenue in Necrotizing Fasciitis Business (2017-2022)
        11.4.5 Teva Pharmaceutical Industries Recent Development
    11.5 Basilea Pharmaceutica
        11.5.1 Basilea Pharmaceutica Company Detail
        11.5.2 Basilea Pharmaceutica Business Overview
        11.5.3 Basilea Pharmaceutica Necrotizing Fasciitis Introduction
        11.5.4 Basilea Pharmaceutica Revenue in Necrotizing Fasciitis Business (2017-2022)
        11.5.5 Basilea Pharmaceutica Recent Development
    11.6 Melinta Therapeutics
        11.6.1 Melinta Therapeutics Company Detail
        11.6.2 Melinta Therapeutics Business Overview
        11.6.3 Melinta Therapeutics Necrotizing Fasciitis Introduction
        11.6.4 Melinta Therapeutics Revenue in Necrotizing Fasciitis Business (2017-2022)
        11.6.5 Melinta Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Necrotizing Fasciitis Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Intravenous Antibiotics
    Table 3. Key Players of Surgery
    Table 4. Key Players of Hyperbaric Oxygen Treatment
    Table 5. Global Necrotizing Fasciitis Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Necrotizing Fasciitis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Necrotizing Fasciitis Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Necrotizing Fasciitis Market Share by Region (2017-2022)
    Table 9. Global Necrotizing Fasciitis Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Necrotizing Fasciitis Market Share by Region (2023-2028)
    Table 11. Necrotizing Fasciitis Market Trends
    Table 12. Necrotizing Fasciitis Market Drivers
    Table 13. Necrotizing Fasciitis Market Challenges
    Table 14. Necrotizing Fasciitis Market Restraints
    Table 15. Global Necrotizing Fasciitis Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Necrotizing Fasciitis Market Share by Players (2017-2022)
    Table 17. Global Top Necrotizing Fasciitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Necrotizing Fasciitis as of 2021)
    Table 18. Ranking of Global Top Necrotizing Fasciitis Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Necrotizing Fasciitis Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Necrotizing Fasciitis Product Solution and Service
    Table 22. Date of Enter into Necrotizing Fasciitis Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Necrotizing Fasciitis Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Necrotizing Fasciitis Revenue Market Share by Type (2017-2022)
    Table 26. Global Necrotizing Fasciitis Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Necrotizing Fasciitis Revenue Market Share by Type (2023-2028)
    Table 28. Global Necrotizing Fasciitis Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Necrotizing Fasciitis Revenue Market Share by Application (2017-2022)
    Table 30. Global Necrotizing Fasciitis Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Necrotizing Fasciitis Revenue Market Share by Application (2023-2028)
    Table 32. North America Necrotizing Fasciitis Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Necrotizing Fasciitis Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Necrotizing Fasciitis Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Necrotizing Fasciitis Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Necrotizing Fasciitis Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Necrotizing Fasciitis Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Necrotizing Fasciitis Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Necrotizing Fasciitis Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Necrotizing Fasciitis Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Necrotizing Fasciitis Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Merck Company Detail
    Table 43. Merck Business Overview
    Table 44. Merck Necrotizing Fasciitis Product
    Table 45. Merck Revenue in Necrotizing Fasciitis Business (2017-2022) & (US$ Million)
    Table 46. Merck Recent Development
    Table 47. Wockhardt Company Detail
    Table 48. Wockhardt Business Overview
    Table 49. Wockhardt Necrotizing Fasciitis Product
    Table 50. Wockhardt Revenue in Necrotizing Fasciitis Business (2017-2022) & (US$ Million)
    Table 51. Wockhardt Recent Development
    Table 52. Atox Bio Company Detail
    Table 53. Atox Bio Business Overview
    Table 54. Atox Bio Necrotizing Fasciitis Product
    Table 55. Atox Bio Revenue in Necrotizing Fasciitis Business (2017-2022) & (US$ Million)
    Table 56. Atox Bio Recent Development
    Table 57. Teva Pharmaceutical Industries Company Detail
    Table 58. Teva Pharmaceutical Industries Business Overview
    Table 59. Teva Pharmaceutical Industries Necrotizing Fasciitis Product
    Table 60. Teva Pharmaceutical Industries Revenue in Necrotizing Fasciitis Business (2017-2022) & (US$ Million)
    Table 61. Teva Pharmaceutical Industries Recent Development
    Table 62. Basilea Pharmaceutica Company Detail
    Table 63. Basilea Pharmaceutica Business Overview
    Table 64. Basilea Pharmaceutica Necrotizing Fasciitis Product
    Table 65. Basilea Pharmaceutica Revenue in Necrotizing Fasciitis Business (2017-2022) & (US$ Million)
    Table 66. Basilea Pharmaceutica Recent Development
    Table 67. Melinta Therapeutics Company Detail
    Table 68. Melinta Therapeutics Business Overview
    Table 69. Melinta Therapeutics Necrotizing Fasciitis Product
    Table 70. Melinta Therapeutics Revenue in Necrotizing Fasciitis Business (2017-2022) & (US$ Million)
    Table 71. Melinta Therapeutics Recent Development
    Table 72. Research Programs/Design for This Report
    Table 73. Key Data Information from Secondary Sources
    Table 74. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Necrotizing Fasciitis Market Share by Type: 2021 VS 2028
    Figure 2. Intravenous Antibiotics Features
    Figure 3. Surgery Features
    Figure 4. Hyperbaric Oxygen Treatment Features
    Figure 5. Global Necrotizing Fasciitis Market Share by Application in 2021 & 2028
    Figure 6. Hospital & Clinics Case Studies
    Figure 7. Surgical Centers Case Studies
    Figure 8. Necrotizing Fasciitis Report Years Considered
    Figure 9. Global Necrotizing Fasciitis Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Necrotizing Fasciitis Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Necrotizing Fasciitis Market Share by Region: 2021 VS 2028
    Figure 12. Global Necrotizing Fasciitis Market Share by Players in 2021
    Figure 13. Global Top Necrotizing Fasciitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Necrotizing Fasciitis as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Necrotizing Fasciitis Revenue in 2021
    Figure 15. North America Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Necrotizing Fasciitis Market Share by Country (2017-2028)
    Figure 17. United States Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Necrotizing Fasciitis Market Share by Country (2017-2028)
    Figure 21. Germany Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Necrotizing Fasciitis Market Share by Region (2017-2028)
    Figure 29. China Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Necrotizing Fasciitis Market Share by Country (2017-2028)
    Figure 37. Mexico Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Necrotizing Fasciitis Market Share by Country (2017-2028)
    Figure 41. Turkey Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Necrotizing Fasciitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Merck Revenue Growth Rate in Necrotizing Fasciitis Business (2017-2022)
    Figure 44. Wockhardt Revenue Growth Rate in Necrotizing Fasciitis Business (2017-2022)
    Figure 45. Atox Bio Revenue Growth Rate in Necrotizing Fasciitis Business (2017-2022)
    Figure 46. Teva Pharmaceutical Industries Revenue Growth Rate in Necrotizing Fasciitis Business (2017-2022)
    Figure 47. Basilea Pharmaceutica Revenue Growth Rate in Necrotizing Fasciitis Business (2017-2022)
    Figure 48. Melinta Therapeutics Revenue Growth Rate in Necrotizing Fasciitis Business (2017-2022)
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Wockhardt
Atox Bio
Teva Pharmaceutical Industries
Basilea Pharmaceutica
Melinta Therapeutics
Frequently Asked Questions
Necrotizing Fasciitis report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Necrotizing Fasciitis report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Necrotizing Fasciitis report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Needle Biopsy

Needle Biopsy market is segmented by players, region (country), by Type and by Application. Playe ... Read More

Nerve Regeneration

Nerve Regeneration market is segmented by players, region (country), by Type and by Application.  ... Read More